Piperacillin-tazo 4.5 g duplexs
Ended Awarded Last action
- Contract number
- SPE2DR26F7MJP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,768
Award facts
- Contract value 100% obligated
- $19,768.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Piperacillin-Tazobactam 4.5G Duplex vials, valued at $19,768.37 under a firm fixed price contract. This non-set-aside delivery order, executed on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide. Piperacillin-Tazobactam is a critical broad-spectrum antibiotic combination commonly used throughout the Department of Defense medical system for treating bacterial infections in military personnel and beneficiaries. AmerisourceBergen's award of this delivery order reflects its established capability to meet federal procurement requirements through competitive award processes and its central role in the DLA's pharmaceutical supply chain supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7MJP?
SPE2DR26F7MJP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F7MJP worth?
The government has obligated $19,768 on SPE2DR26F7MJP.
Is contract SPE2DR26F7MJP an order under another contract?
Yes. SPE2DR26F7MJP is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MJP competed?
The extent of competition for SPE2DR26F7MJP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award